facebook-page-view
Advertisement

GSK Velu's Neuberg takes M&A route after missing revenue target

By Anuj Suvarna

  • 24 Apr 2023
Premium
GSK Velu's Neuberg takes M&A route after missing revenue target
GSK Velu, founder, Neuberg Diagnostics | Credit: GSK Velu/LinkedIn

Neuberg Diagnostics Pvt. Ltd, the pathology chain set up by healthcare entrepreneur GSK Velu more than five years ago, has struck an inorganic deal to expand its operations after missing its revenue target.  Velu had set up Neuberg in 2017, two years after selling his stake in pathology chain Metropolis Healthcare ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement